Healthcare / Health Information ServicesHelsinki
$0.96
+0.06 (+6.46%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-13.0M · quality 72.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
23/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$58M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-27.9%
↓Gross Margin
75.4%
↑Debt/Equity
0.05
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+26.6%
FCF CAGR
—
FCF margin
-303.9%
FCF / Net income
0.77x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.7M · net income $-18.5M · FCF $-14.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.7M | $4.7M | $4.4M | $4.2M | $2.3M |
| Net Income | $-18.5M | $-18.5M | $-17.5M | $-18.1M | $-16.1M |
| EBITDA | $-8.8M | $-8.8M | $-8.4M | $-11.4M | $-11.2M |
| EPS | -0.31 | -0.31 | -0.29 | -0.30 | -0.27 |
| Gross Margin | 75.4% | 75.4% | 66.5% | 85.9% | 55.2% |
| Operating Margin | -413.4% | -413.4% | -427.8% | -447.1% | -590.3% |
| Net Margin | -393.4% | -393.4% | -400.7% | -432.4% | -695.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.05 | 0.05 | 0.03 | 0.05 | 0.07 |
| Current Ratio | 8.53 | 8.53 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-14.3M | $-14.3M | $-13.0M | $-11.7M | $-15.1M |
| Returns | |||||
| ROE | -27.9% | -27.9% | -21.1% | -18.6% | -14.4% |
| Valuation | |||||
| P/B | 0.87 | 0.87 | 1.79 | 0.52 | 0.98 |
| Growth & Yield | |||||
| Revenue Growth | 7.7% | 7.7% | 4.2% | 80.8% | — |
| EPS Growth | -6.9% | -6.9% | 3.3% | -11.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-66.3%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.29 → -0.31
Residual
-66.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.